Novacyt (ALNOV.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | ||||
| Accounts receivable | 59 | N/A | N/A | N/A |
| Other Working Capital | 1,248 | -433 | 94 | -42 |
| Other Operating Activity | -1,987 | -465 | -279 | -439 |
| Operating Cash Flow | $-679 | $-898 | $-184 | $-481 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -472 | -309 | -471 | -167 |
| Net Acquisitions | -277 | N/A | N/A | N/A |
| Investing Cash Flow | $-748 | $-309 | $-471 | $-167 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | 12 | 64 | 11 | 110 |
| Debt Repayment | -127 | -821 | -546 | -393 |
| Common Stock Issued | 2,463 | 1,401 | 2,526 | 867 |
| Common Stock Repurchased | -27 | N/A | N/A | N/A |
| Other Financing Activity | 16 | 0 | 0 | 0 |
| Financing Cash Flow | $2,335 | $643 | $1,991 | $584 |
| Exchange Rate Effect | 19 | N/A | N/A | N/A |
| Beginning Cash Position | 774 | 1,401 | 34 | 99 |
| End Cash Position | 1,699 | 837 | 1,369 | 35 |
| Net Cash Flow | $908 | $-564 | $1,335 | $-65 |
| Free Cash Flow | ||||
| Operating Cash Flow | -679 | -898 | -184 | -481 |
| Capital Expenditure | -488 | -309 | -471 | -167 |
| Free Cash Flow | -1,166 | -1,207 | -656 | -648 |